PNC Financial Services Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.16K Buy
548
+538
+5,380% +$4.82K ﹤0.01% 4374
2026
Q1
$81 Hold
10
﹤0.01% 5106
2025
Q4
$67 Sell
10
-535
-98% -$4.03K ﹤0.01% 5087
2025
Q3
$4.73K Buy
545
+153
+39% +$1.19K ﹤0.01% 4228
2025
Q2
$2.47K Sell
392
-1,365
-78% -$9.04K ﹤0.01% 4356
2025
Q1
$11.3K Buy
1,757
+16
+0.9% +$132 ﹤0.01% 3785
2024
Q4
$14K Sell
1,741
-1,670
-49% -$16.1K ﹤0.01% 3682
2024
Q3
$43.1K Sell
3,411
-415
-11% -$5.36K ﹤0.01% 3165
2024
Q2
$48.4K Sell
3,826
-511
-12% -$5.14K ﹤0.01% 3052
2024
Q1
$20.7K Buy
4,337
+949
+28% +$4.4K ﹤0.01% 3434
2023
Q4
$16.3K Buy
3,388
+984
+41% +$6.02K ﹤0.01% 3547
2023
Q3
$17.4K Buy
2,404
+1,210
+101% +$9.67K ﹤0.01% 3496
2023
Q2
$8.87K Buy
1,194
+691
+137% +$5.43K ﹤0.01% 3926
2023
Q1
$3.49K Buy
503
+84
+20% +$773 ﹤0.01% 4157
2022
Q4
$4.31K Sell
419
-266
-39% -$4.69K ﹤0.01% 4040
2022
Q3
$12K Sell
685
-80
-10% -$3.47K ﹤0.01% 3673
2022
Q2
$40K Sell
765
-159
-17% -$8.24K ﹤0.01% 3135
2022
Q1
$68K Sell
924
-214
-19% -$19.1K ﹤0.01% 2939
2021
Q4
$164K Sell
1,138
-520
-31% -$89.3K ﹤0.01% 2381
2021
Q3
$344K Sell
1,658
-78
-4% -$17.2K ﹤0.01% 1860
2021
Q2
$368K Buy
1,736
+518
+43% +$94.9K ﹤0.01% 1817
2021
Q1
$220K Buy
1,218
+306
+34% +$61K ﹤0.01% 2117
2020
Q4
$101K Buy
912
+120
+15% +$12.8K ﹤0.01% 2480
2020
Q3
$86K Buy
792
+67
+9% +$8.16K ﹤0.01% 2413
2020
Q2
$61K Buy
725
+500
+222% +$19.1K ﹤0.01% 2650
2020
Q1
$3K Buy
225
+215
+2,150% +$1.82K ﹤0.01% 3682
2019
Q4
$0 Buy
+10
New +$43 ﹤0.01% 4067
2017
Q1
Sell
-360
Closed -$10K 4173
2016
Q4
$10K Sell
360
-213
-37% -$6.21K ﹤0.01% 3487
2016
Q3
$23K Buy
573
+1
+0.2% +$129 ﹤0.01% 3156
2016
Q2
$83K Sell
572
-1,760
-75% -$202K ﹤0.01% 2578
2016
Q1
$241K Sell
2,332
-8,287
-78% -$889K ﹤0.01% 1979
2015
Q4
$1.78M Sell
10,619
-100
-0.9% -$15.4K ﹤0.01% 956
2015
Q3
$1.52M Buy
10,719
+102
+1% +$22.9K ﹤0.01% 1064
2015
Q2
$2.37M Buy
10,617
+33
+0.3% +$5.8K ﹤0.01% 912
2015
Q1
$1.75M Buy
10,584
+559
+6% +$90.8K ﹤0.01% 1016
2014
Q4
$1.19M Hold
10,025
﹤0.01% 1125
2014
Q3
$836K Hold
10,025
﹤0.01% 1190
2014
Q2
$926K Buy
10,025
+1,325
+15% +$116K ﹤0.01% 1123
2014
Q1
$788K Sell
8,700
-10
-0.1% -$1.12K ﹤0.01% 1166
2013
Q4
$892K Buy
8,710
+10
+0.1% +$707 ﹤0.01% 1081
2013
Q3
$548K Buy
+8,700
New +$490K ﹤0.01% 1293

Other funds holding NVAX

PNC Financial Services Group's NVAX Position: Q2 2026 in Review

PNC Financial Services Group increased its Novavax (NVAX) stake by 5,380% in Q2 2026, buying an estimated $4.82K and bringing the position to 548 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4374.

PNC Financial Services Group first reported a position in NVAX in Q3 2013 and has held it in 41 quarters since. The position peaked at $2.37M in Q2 2015. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • PNC Financial Services Group held 548 shares of Novavax worth $5.16K as of Q2 2026.
  • PNC Financial Services Group bought 538 Novavax shares in Q2 2026, an estimated $4.82K.
  • Novavax made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4374 holding.
  • PNC Financial Services Group first reported a position in Novavax in Q3 2013 and has held it in 41 quarters since.
  • PNC Financial Services Group's Novavax position peaked at $2.37M in Q2 2015.
  • 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.